The Synthesis of Glutamine-Functionalized Block Polymer and Its Application in Triple-Negative Breast Cancer Treatment
Triple-negative breast cancer (TNBC) is a highly malignant tumor. At present, there are still no targeted drugs for TNBC. Clinical chemotherapeutic drugs, such as doxorubicin (DOX), have the characteristic of nontargeted distribution in treatment of TNBC, causing severe side effects. Therefore, new...
Main Authors: | Yi-Zhi Zhu, Di Xu, Zhen Liu, Tian Tian, Fei Deng, Wen-Juan Tang, Yang Wu, Wei Zhang, Jin-Hai Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Journal of Nanomaterials |
Online Access: | http://dx.doi.org/10.1155/2020/4943270 |
Similar Items
-
Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer
by: Hu, Y., et al.
Published: (2022) -
Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation
by: Zhi-Ling Li, et al.
Published: (2020-07-01) -
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
by: Bo Chen, et al.
Published: (2017-05-01) -
The role and function of SOX11 in DNA damage in triple-negative breast cancer
by: Lee, Tian Yu
Published: (2019) -
Novel Aminoglycoside Polymers and Combination Treatments in Triple Negative Breast Cancer Studies
Published: (2018)